DocuSign, Inc. — Q3 FY2024 Form 10-Q
Reporting period: Three and nine months ended October 31, 2023; fiscal year ends January 31. Amounts below are U.S. dollars. Financial statements are unaudited.
Business context
DocuSign provides eSignature and broader agreement-workflow products, primarily through subscriptions. Subscription revenue represented 97% of revenue. The company reported more than 1.4 million customers, including approximately 233,000 enterprise and commercial customers, versus approximately 202,000 a year earlier. No customer accounted for more than 10% of revenue.
Financial performance
| Metric | Q3 FY2024 | Q3 FY2023 | Nine months FY2024 | Nine months FY2023 |
|---|---|---|---|---|
| Revenue | $700.4 million (+9%) | $645.5 million | $2,049.5 million (+10%) | $1,856.3 million |
| GAAP gross margin | 80% | 80% | 79% | 79% |
| Operating income (loss) | $19.7 million | $(27.4) million | $21.7 million | $(87.7) million |
| Net income (loss) | $38.8 million | $(29.9) million | $46.7 million | $(102.3) million |
| Operating cash flow | $264.2 million | $52.5 million | $708.8 million | $369.7 million |
| Free cash flow (non-GAAP) | $240.3 million | $36.1 million | $638.6 million | $316.1 million |
- Q3 subscription revenue was $682.4 million, up 9%; professional services and other revenue was $18.1 million, down 16%. Nine-month subscription revenue rose 11% to $1,991.0 million.
- Q3 GAAP operating margin was 3%, versus negative 4% a year earlier; GAAP net margin was approximately 6%, versus negative 5%. Nine-month operating margin was 1%, versus negative 5%.
- Q3 non-GAAP operating income was $187.4 million, with a 27% margin, versus $147.1 million and 23% a year earlier. Nine-month non-GAAP operating income was $533.0 million, with a 26% margin. Non-GAAP net income was $163.8 million for the quarter and $463.6 million for nine months. These measures exclude substantial items, especially stock-based compensation.
- Non-GAAP billings were $691.8 million for Q3 versus $659.4 million, and $2,077.8 million for nine months versus $1,920.7 million.
- Cash and cash equivalents were $1,188.6 million; current investments were $401.6 million and noncurrent investments $55.4 million at October 31. The filing describes cash, cash equivalents, restricted cash and investments as approximately $1.7 billion. Nine-month cash increased by $470.3 million.
- Total liabilities were $2,372.6 million and stockholders’ equity $965.0 million. The balance sheet classified $689.1 million of convertible notes as current. The $690 million principal 0% notes were due January 15, 2024; the prior $37.1 million of 2023 notes was repaid at maturity in September 2023. The $500 million revolving facility, expandable by up to $250 million, had no borrowings; the company reported covenant compliance.
- Stock-based compensation was $159.4 million in Q3 and $455.8 million for nine months. The company repurchased $75.0 million of shares in Q3 and $145.5 million year to date.
Changes versus prior comparable periods
- Revenue growth continued, while GAAP profitability improved from losses to income. Operating cash flow and free cash flow also increased substantially year over year.
- Q3 sales and marketing expense fell 7% to $292.5 million, while research and development rose 18% to $136.6 million and general and administrative expense rose 26% to $108.2 million. The latter increases included higher stock-based compensation, personnel and professional-services costs.
- Interest income and other income, net, rose to $17.7 million in Q3 from $0.8 million, largely reflecting higher interest income. For nine months it was $47.4 million versus an expense of $2.8 million.
- International revenue was 26% of Q3 revenue, compared with 24% a year earlier; it was 26% for nine months versus 25%.
Outlook, risks and contingencies
- The filing provides no numerical revenue or earnings guidance. Management said existing cash, investments, expected operating cash flows and available credit were adequate for working capital and capital expenditure needs for at least 12 months, including the January 2024 note maturity. It also said operating losses may continue for the foreseeable future as it invests in the business.
- Management cited customer acquisition, renewal and expansion, international growth, product innovation and investment in research and development as priorities. It identified macroeconomic conditions, competition, slower eSignature adoption, sales-cycle variability, cybersecurity and service availability, privacy regulation, and successful development of AI-enabled products among material risks.
- Restructuring plans were substantially completed: the 2023 plan by the end of fiscal 2023 and the 2024 plan by Q2 FY2024. Nine-month restructuring charges were $30.3 million, primarily employee termination benefits; Q3 charges were $0.7 million.
- A securities class action alleging misleading statements about business and prospects is proceeding after the court denied a motion to dismiss. Related shareholder derivative suits are stayed. Former CEO Daniel Springer’s arbitration includes claims for unspecified damages; the hearing was scheduled for March 2024. The company said it believes the outcome of these matters will not materially adversely affect it, but outcomes are uncertain.
- Remaining performance obligations for contracts longer than one year were $2.0 billion; the company expected to recognize 58% within the following 12 months. It also disclosed a remaining $138.4 million commitment under a cloud-provider agreement through fiscal 2028, separate from other listed contractual commitments.
Important facts for investors to verify
- How the January 15, 2024 convertible-note maturity was settled, including cash use, conversion and any subsequent financing disclosures.
- Whether revenue growth, billings, customer retention and expansion continued after the reporting date, particularly given the nearly flat count of customers above $300,000 annualized contract value.
- Whether operating profitability and cash generation are sustainable, considering stock-based compensation, restructuring, and elevated general and administrative and research and development costs.
- Developments in the securities litigation and former CEO arbitration, including any material change in exposure or timing.
- Execution and economics of product expansion, including AI offerings, and the effect of competition, cybersecurity, regulation and macroeconomic conditions.